Abzena
Abzena offers Antibody and bioconjugate characterization and analytical development. This is the analytical service business of an integrated CRO/CDMO.
Corporate information
- Company entity
- Abzena
- Ownership / capital status
- PrivatePrivately held; latest independently attributable funding amount not verified ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗
- Official corporate reference
- https://abzena.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Discuss this company with the research assistant
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Abzena offers Antibody and bioconjugate characterization and analytical development. This is the analytical service business of an integrated CRO/CDMO.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Biologics Process Development Services | Abzena
- Abzena | LinkedIn
- Analytical Method Development | Biologics Analytical Development | Abzena
- About Us | Moving Medicine Forward | Abzena